It's Past Time To Retake Control Of America's Drug Supply
Source: Life Science Leader
By Bill Wiederseim
In the not-so-distant past, America was number one in pharmaceutical innovation, manufacturing excellence, and product quality, in large part because U.S. pharmaceutical companies had ultimate control over their supply chains, manufacturing facilities, and packaging operations. Those days are gone.
Today, Asia produces most of the small-molecule APIs used to make generic and branded prescription drugs sold in the U.S. The U.S. drug supply is 90 percent generic, by volume, with some 80 percent of the APIs used to make these generics, as well as branded drugs, coming from China or India.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more